Navigation Links
SGX Pharmaceuticals Submits Investigational New Drug Application for SGX393
Date:6/30/2008

able at a future date.

About SGX Pharmaceuticals

SGX Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development and commercialization of novel, targeted therapeutics directed at addressing unmet medical needs in oncology. The Company's drug development programs target the MET receptor tyrosine kinase, an enzyme implicated in a broad array of cancers, and the BCR-ABL tyrosine kinase enzyme for the treatment of CML. The Company's drug discovery activities are focused on a portfolio of other protein and enzyme targets that have been implicated in human cancers, including JAK2, RON, ALK, RAS and IKKe. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.

Forward Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to, the potential of SGX393 as a treatment for CML, and the ability of the company to discover, develop and commercialize cancer therapeutics. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the risks and uncertainties inherent in drug discovery, development and commercialization. The results of early preclinical studies or clinical trials may not be predictive of future results, and the Company cannot provide any assurances that any of its compounds or development candidates will have favorable results in preclinical studies or future clinical trials or that the FDA will approve the commencement of clinical trials. For a discussion of these and other factors, please refer to the risk factors descri
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. VIA Pharmaceuticals Set to Join Russell Microcap Index
2. Wyeth Pharmaceuticals Announces Organizational Change
3. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
4. Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
5. Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations
6. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
7. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
8. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
9. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
10. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that ... Matsuda, Horiba Scientific, have organized a session on nanotechnology ... JASIS , Asia’s largest analytical and scientific instruments show, ... Japan. , The four speakers in this U.S. ... Molecules to Single Cells” will present their use of ...
(Date:8/29/2014)... August 29, 2014 Three Lawrence ... 2014 Hydrogen Production R&D Award for ... splitting water using sunlight. , Shared with collaborators ... the University of Nevada, Las Vegas (UNLV), the ... models of photoelectrochemical solar-hydrogen production and corrosion processes. ...
(Date:8/29/2014)... Antonio, TX (PRWEB) August 29, 2014 ... and ISO 13485:2003 certified, GAMP® 5 compliant imaging ... awarded an international Phase II clinical trial to ... lymphoma. , Throughout this trial, Intrinsic Imaging will ... not limited to, protocol and charter development, site ...
(Date:8/28/2014)... Ca. (PRWEB) August 28, 2014 Best ... rating for an alcohol-based hand sanitizer, asks food processors ... by comparing the hand sanitizer they’re currently using to ... . Hand hygiene is critical to fighting cross-contamination and ... Best Sanitizers believes there are key criteria that ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Livermore Team Awarded for Hydrogen Production Research 2Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3
... 26, 2011 HollisterStier Allergy announced that they ... of the business, illustrating the continued investment in ... Sciences, Ltd (Jubilant).   (Photo:   ... years of healthcare experience, 15 of which involved ...
... 26, 2011 Gen-Probe Incorporated (NASDAQ: GPRO ) ... Securities, 26th Annual Health Care Conference in Boston on May ... 2nd Annual Health Care Conference in New York on May ... be webcast live and may be accessed through a link ...
... NEW YORK, April 26, 2011 Reportlinker.com announces ... in its catalogue: R&D Trends: ... treatment http://www.reportlinker.com/p0484932/RD-Trends-Osteoporosis---Strong-pipeline-bodes-well-for-future-treatment.html ... been encouraging developments in the osteoporosis pipeline, with ...
Cached Biology Technology:Kevin Garrity Named President of HollisterStier Allergy 2Gen-Probe to Webcast Two Upcoming Investor Presentations 2Reportlinker Adds R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment 2Reportlinker Adds R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment 3
(Date:8/29/2014)... at the Barshop Institute for Longevity and Aging Studies, ... Health Science Center at San Antonio, have found another ... rodent, the naked mole rat. , They reported ... rats protects and alters the activity of the proteasome, ... The factor also protects proteasome function in human, mouse ...
(Date:8/29/2014)... news release is available in German . ... key players in the natural nitrogen cycle on Earth ... specialist bacteria were thought to depend on nitrite as ... led by Holger Daims, a microbiologist at the University ... use hydrogen as an alternative source of energy. The ...
(Date:8/29/2014)... of the Tibetan plateau -- the largest topographic anomaly ... both its profound effect on climate and its reflection ... GSA Bulletin , Katharine Huntington and colleagues employ a ... modern and fossil snail shells to investigate the uplift ... , Views range widely on the timing of surface ...
Breaking Biology News(10 mins):Factor in naked mole rat's cells enhances protein integrity 2Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7
... collaboration led by biologists and neuroscientists at the University of ... is the cause of cognitive impairment due to sleep deprivation. ... deficits caused by sleep deprivation, such as an inability to ... concentration of a specific enzyme that builds up in the ...
... Cincinnati, OH (October 26, 2009) Inspired by recent ... (IRSF) announced a major fundraising initiative entitled Research to ... are earmarked to accelerate the progress of crucial research, ... Clint Black, whose niece Courtney lost her battle with ...
... for Virology and Experimental Chemotherapy (Rega Institute) and the "Centre ... a total of 2.8 million euro from the British Wellcome ... possible new medication for the treatment of infections related to ... in tropical and subtropical regions. As of yet, there is ...
Cached Biology News:Fighting sleep, Penn researchers reverse the cognitive impairment caused by sleep deprivation 2IRSF receives $1 million matching gift 2IRSF receives $1 million matching gift 3Wellcome Trust funds dengue fever research in Leuven 2
... The inductive drives of VARIOMAG Magnetic ... as motors, belts, or mechanical bearings, making ... In addition, the VARIOMAG inductive drive can ... water, dust or microorganisms. This is why ...
... Fluoroskan Ascent FL ... fluorometric and luminometric measurement ... long list of advanced ... and Luminoskan Ascent. Fluoroskan ...
...
... The Jouan MSC series of Class ... working conditions and certification to the ... regulation ensures that the cabinets cannot ... conditions. Natural lighting, low noise and ...
Biology Products: